'Frans van de werf' presentation slideshows

Supported by a grant from Novartis Pharmaceuticals

VAL sartan I n A cute myocardial i N farc T ion.

463 views • 30 slides

Pulmonary Embolism Thrombolysis Study an investigator-initiated, investigator-sponsored trial

Pulmonary Embolism Thrombolysis Study an investigator-initiated, investigator-sponsored trial. The PEITH Investigators. ClinicalTrials.gov # NCT00639743 EudraCT # 2006-005328-18. Rationale: risk-adjusted treatment of acute PE. Thrombolysis?. Primary

610 views • 27 slides

The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Tri

ASSENT- 4 PCI Trial. The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial. Presented at The European Society of Cardiology Hot Line Session 2005 Presented by Dr. Frans Van de Werf. ASSENT- 4 PCI Trial.

480 views • 25 slides

clinicaltrials Identifier: NCT00699998

479 views • 19 slides

Funding: The TRACER trial was funded by Merck & Co., Inc.

225 views • 14 slides

Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Stenting: the TRITON -

STENT ANALYSIS. Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Stenting: the TRITON - TIMI 38 Stent Analysis .

356 views • 10 slides